2009 OPPS Final Rule Corrected

The Centers for Medicare & Medicaid Services (CMS) published Jan. 26 in the Federal Register a correction (FR Doc E9-1519) to the 2009 Outpatient Prospective Payment System (OPPS)/Ambulatory Surgical Center (ASC) final rule regarding HCPCS code J3300.

HCPCS code J3300 Injection, triamcinolone acetonide, preservative free, 1 mg was incorrectly assigned status indicator “N.” This error appears in Addendum B on page 69228 of the 2009 OPPS/ASC final rule.

Ambulatory Surgical Center CASCC

HCPCS code J3300 should have a status indicator “K” Nonpass-through drugs and biologicals; paid under OPPS; separate APC payment.

As a result of this error, in Addendum A, on page 68831, CMS has added APC 1253 Triamcinolone A inj PRS-free with status indicator “K;” and in Addendum BB, on page 69301, CMS has changed the ASC payment indicator for J3300 from “N1” to “K2” Drugs and biologicals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate.

The corrected payment rate for HCPCS code J3300 is $3.18.

Latest posts by admin aapc (see all)

Read the complete Article

Login as a member or sign up for free to get uninterrupted access to AAPC blog posts and stay updated on industry news through our monthly newsletter.


One Response to “2009 OPPS Final Rule Corrected”

  1. Cindy says:

    Question #5 of the EdgeBlast 118 Test Yourself asks about J3330. It should be J3300.

Leave a Reply

Your email address will not be published. Required fields are marked *